Drug intelligence / Profile preview

hexobarbital

Development stage
Unknown
Lead developer
I.G. Farben
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Hexobarbital is a barbiturate derivative with hypnotic and sedative effects. It was primarily used in the 1940s and 1950s as an anesthetic for surgery and as a rapid-acting, short-lasting hypnotic. Hexobarbital has a relatively fast onset of action and short duration of effect. Its use in human medicine has largely been replaced by safer alternatives such as thiopental due to difficulties in controlling anesthesia depth. The mechanism of action involves binding to a distinct site on the GABA-A receptor chloride ionophore complex, increasing the duration that the chloride channel remains open. This potentiates GABAergic inhibition in the central nervous system by prolonging post-synaptic inhibitory effects[1][3][7].

Brand names
CitopanEvipanTobinal
Other names
hexobarbitonemethylhexabitalmethexenyl
02

Targets

GABRR (GABA-A receptor subunit rho)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on hexobarbital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hexobarbital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call